242 pharm exam 1 Samenvattingen, Notities en Examens

Exam (elaborations) NUR 210, 242 Pharm Exam 1.(NUR 210, 242Pharm Exam 1. (NUR 210, 242 Pharm Exam 1.(NUR 210, 242Pharm Exam 1)

NUR 210, 242 - Pharm Exam 1 Study Guide(100% correct)/NUR 210, 242 - Pharm Exam 1 Study Guide(100% correct).

NUR 210, 242 -Exam 3 Pharm Study Guide (100% correct). Exam 3 pharm study guide Loop, potassium-sparing, and thiazide diuretics Drug classification Thiazides Thiazide-like diuretics Loop High ceiling diuretics Thiazide Action Potassium-sparing Potassium sparing diuretics Acts on the distal convoluted renal tube. Promotes sodium, chloride, and water excretion Indications Hydrochlorothiazide Decrease blood pressure Decrease amount of fluid within the body Treats pe...

NUR 210, 242 Exam 3 pharm study guide Loop,potassium-sparing, and thiazide diuretics Drug classification Thiazides Thiazide-like diuretics Loop High ceiling diuretics Thiazide Action Potassium-sparing Potassium sparing diuretics Acts on the distal convoluted renal tube. Promotes sodium, chloride, and water excretion Indications Hydrochlorothiazide Decrease blood pressure Decrease amount of fluid within the body Treats peripheral edema Side effects Hyperglyc...

NSG 6001 Study Guide questions with correct answers rated A+ Return to deck 1. Ray has been diagnosed with hypertension and an ACE inhibitor is determined to be needed. Prior to prescribing this drug, the NP should assess for: A. Hypokalemia B. Impotence C. Decreased renal function D. Inability to concentrate 2. Carbamazepine has a Black Box warning recommending testing for the HLA-B*1502 allele in patients with Asian ancestry prior to starting therapy due to: C. Increased risk for...

NSG 6001 Study Guide questions with correct answers rated A+ Return to deck 1. Ray has been diagnosed with hypertension and an ACE inhibitor is determined to be needed. Prior to prescribing this drug, the NP should assess for: A. Hypokalemia B. Impotence C. Decreased renal function D. Inability to concentrate 2. Carbamazepine has a Black Box warning recommending testing for the HLA-B*1502 allele in patients with Asian ancestry prior to starting therapy due to: C. Increased risk for...